García-López MT - Search Results

1

5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptors.

Muñoz-Ruiz P, García-López MT, Cenarruzabeitia E, Del Río J, Dufresne M, Foucaud M, Fourmy D, Herranz R. Muñoz-Ruiz P, et al. J Med Chem. 2004 Oct 7;47(21):5318-29. doi: 10.1021/jm0498755. J Med Chem. 2004. PMID: 15456276

2

Effects of the incorporation of IBTM beta-turn mimetics into the dipeptoid CCK(1) receptor agonist PD 170292.

Martín-Martínez M, Latorre M, García-López MT, Cenarruzabeitia E, Del Río J, González-Muñiz R. Martín-Martínez M, et al. Bioorg Med Chem Lett. 2002 Jan 21;12(2):109-12. doi: 10.1016/s0960-894x(01)00630-8. Bioorg Med Chem Lett. 2002. PMID: 11755332

3

2-Oxopiperazine-based gamma-turn conformationally constrained peptides: synthesis of CCK-4 analogues.

Herrero S, García-López MT, Latorre M, Cenarruzabeitia E, Del Río J, Herranz R. Herrero S, et al. J Org Chem. 2002 May 31;67(11):3866-73. doi: 10.1021/jo0256336. J Org Chem. 2002. PMID: 12027705

4

Analogues of the neuroprotective tripeptide Gly-Pro-Glu (GPE): synthesis and structure-activity relationships.

Alonso De Diego SA, Muñoz P, González-Muñiz R, Herranz R, Martín-Martínez M, Cenarruzabeitia E, Frechilla D, Del Río J, Jimeno ML, García-López MT. Alonso De Diego SA, et al. Bioorg Med Chem Lett. 2005 May 2;15(9):2279-83. doi: 10.1016/j.bmcl.2005.03.015. Bioorg Med Chem Lett. 2005. PMID: 15837309

5

Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor.

Martín-Martínez M, Marty A, Jourdan M, Escrieut C, Archer E, González-Muñiz R, García-López MT, Maigret B, Herranz R, Fourmy D. Martín-Martínez M, et al. J Med Chem. 2005 Jul 28;48(15):4842-50. doi: 10.1021/jm0501127. J Med Chem. 2005. PMID: 16033264

6

Conformationally constrained CCK4 analogues incorporating IBTM and BTD beta-turn mimetics.

Martín-Martínez M, De la Figuera N, Latorre M, García-López MT, Cenarruzabeitia E, Del Río J, González-Muñiz R. Martín-Martínez M, et al. J Med Chem. 2005 Dec 1;48(24):7667-74. doi: 10.1021/jm050689o. J Med Chem. 2005. PMID: 16302807

7

New Gly-Pro-Glu (GPE) analogues: expedite solid-phase synthesis and biological activity.

Alonso De Diego SA, Gutiérrez-Rodríguez M, Pérez de Vega MJ, Casabona D, Cativiela C, González-Muñiz R, Herranz R, Cenarruzabeitia E, Frechilla D, Del Río J, Jimeno ML, García-López MT. Alonso De Diego SA, et al. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1392-6. doi: 10.1016/j.bmcl.2005.11.040. Bioorg Med Chem Lett. 2006. PMID: 16321525

8

The neuroprotective activity of GPE tripeptide analogues does not correlate with glutamate receptor binding affinity.

Alonso De Diego SA, Gutiérrez-Rodríguez M, Pérez de Vega MJ, González-Muñiz R, Herranz R, Martín-Martínez M, Cenarruzabeitia E, Frechilla D, Del Río J, Jimeno ML, García-López MT. Alonso De Diego SA, et al. Bioorg Med Chem Lett. 2006 Jul 1;16(13):3396-400. doi: 10.1016/j.bmcl.2006.04.033. Epub 2006 May 2. Bioorg Med Chem Lett. 2006. PMID: 16650992

9

Strategies for design of non peptide CCK1R agonist/antagonist ligands.

García-López MT, González-Muñiz R, Martín-Martínez M, Herranz R. García-López MT, et al. Curr Top Med Chem. 2007;7(12):1180-94. doi: 10.2174/156802607780960537. Curr Top Med Chem. 2007. PMID: 17584140 Review.

10

Thrombin-activated receptors: promising targets for cancer therapy?

García-López MT, Gutiérrez-Rodríguez M, Herranz R. García-López MT, et al. Curr Med Chem. 2010;17(2):109-28. doi: 10.2174/092986710790112639. Curr Med Chem. 2010. PMID: 19941475 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page